The US Food and Drug Administration’s top vaccine official overrode agency experts in May to recommend against the broad use ...

The multicomponent mRNA-1083 vaccine elicited noninferior immune responses in adult patients when compared with coadministered influenza and COVID-19 vaccines.

The government’s top vaccine official, working under Health Secretary Robert F. Kennedy Jr., restricted the approval of two ...

The new memos from the Food and Drug Administration show how the agency’s vaccine chief, Dr. Vinay Prasad, personally ...

The use of TNF-α inhibitors among patients with hidradenitis suppurativa did not affect seroconversion following mRNA vaccination for COVID-19.

Amid fresh surge in Covid-19 cases, a team of US researchers has developed a new type of mRNA vaccine that is more scalable and adaptable to tackle continuously evolving viruses such as SARS-CoV-2 ...

According to the CDC, though rare, these side effects most often affect young adult males within 7 days of their second mRNA COVID-19 vaccine dose. Currently approved mRNA vaccines include Moderna ...

Amid a fresh wave of COVID-19, American researchers have now found a news type of mRNA vaccine to prevent the deadly disease. A team of US researchers have found that the vaccine is more scalable and ...

The Moderna vaccine is also known as the mRNA-1273 vaccine. It is one of the vaccines currently available to protect people against COVID-19.

The vaccine is expected to be available for eligible patients for the 2025-2026 season, alongside Spikevax ® (COVID-19 Vaccine, mRNA).